Diffuse large B-cell lymphoma: open trials in Greece

• NCT05139017

  A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)

  Trial Treatment · Phase 2/3 · Merck Sharp & Dohme LLC

  University General Hospital of Alexandroupoli, Alexandroupoli · Evangelismos S A, Athens · Laiko General Hospital of Athens, Athens

  Registry updated 2026-11-03

• NCT06395103

  Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

  Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC

  Nosokomeio Paidon I Agia Sofia, Athens

  Registry updated 2026-10-30

• NCT06717347

  A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  University General Hospital of Alexandroupoli, Alexandroupoli · Laiko General Hospital of Athens, Athens · Evangelismos S A, Athens · University General Hospital Attikon, Athens

  Registry updated 2026-10-21

• NCT05735704

  Early Detection and Screening of Hematological Malignancies - SANGUINE

  Research · JaxBio Ltd

  National and Kapodistrian University of Athens (NKUA), Athens

  Registry updated 2026-10-15

• NCT06980116

  Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies

  Trial Treatment · Phase 1 · Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.

  Laiko General Hospital of Athens, Athens · General University Hospital Of Patras, Patras · Geniko Nosokomeio Thessalonikis George Papanikolaou, Thessaloniki

  Registry updated 2026-08-13

• NCT05820841

  Acalabrutinib in Combination With R-miniCHOP in Older Adults With Untreated Diffuse Large B-Cell Lymphoma

  Trial Treatment · Phase 3 · Universität des Saarlandes

  University Hospital of Alexandroupolis, Alexandroupolis · Laiko General Hospital of Athens, Athens · University General Hospital Attikon, Athens · University General Hospital of Ioannina, Ioannina · General University Hospital Of Patras, Patras · Theageneio Cancer Hospital, Thessaloniki

  Registry updated 2026-06-29

• NCT06830759

  Real-World Study to Assess Subcutaneous Epcoritamab in Adult Participants With Diffuse Large B-Cell and Follicular Lymphoma

  Research · AbbVie

  University General Hospital of Alexandroupoli /ID# 272737, Alexandroupoli · General Hospital of Athens Laiko /ID# 272758, Athens · University General Hospital Attikon /ID# 272738, Athens · Evangelismos Hospital /ID# 272736, Athens · University Hospital of Ioannina /ID# 272739, Ioannina · Agios Andreas Hospital Patras /ID# 273629, Pátrai · Metaxa Cancer Hospital Of Piraeus /ID# 273623, Piraeus · General Hospital Of Thessaloniki G. Papanikolaou /ID# 275323, Thessaloniki · General Hospital of Thessaloniki Hippokrateio /ID# 273635, Thessaloniki · AHEPA University General Hospital of Thessaloniki /ID# 273633, Thessaloniki · Papageorgiou General Hospital /ID# 272735, Thessaloniki

  Registry updated 2026-02-17

All Diffuse large B-cell lymphoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error